Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
    • Transskriptioner
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team
Selskabsmeddelelse

AMBU’S SHARE BUYBACK PROGRAM HAS BEEN FINALIZED

Ambu

12.2.2026 09:37:21 CET | Ambu A/S | Changes in company's own shares

On 10 December 2025, Ambu announced a share buyback program (company announcement no. 7 2025/26). The share buyback program was carried out in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) (as amended) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, also referred to as the Safe Harbor Regulations.                                                                                         

During the program, Ambu has repurchased shares for a total amount of DKK 150m since 10 December 2025. The program had to be completed no later than 31 March 2026. The repurchased shares are bought with the aim of completing a share capital decrease as set out in Article 5(2)(a) in MAR.

The following transactions have been made under the program from 09 February to 11 February 2026:

 

Number of shares

Average purchase price, DKK

Transaction value, DKK

Accumulated under the program after last announcement

1,673,984

86.0217

143,998,989

2026.02.09

0

0.0000

 -  

2026.02.10

0

0.0000

 -  

2026.02.11

72,050

83.2889

 6,000,965

Accumulated under the program

1,746,034

85.9090

149,999,954

After the above mentioned transactions, the share buyback program has now been concluded. Ambu now owns 4,195,158 treasury shares, corresponding to 1.6% of the share capital.

 

Contacts

  • Anders Hjort, Head of Investor Relations, +45 2892 8881, anhj@ambu.com
  • Tine Bjørn Schmidt, Director of Corporate Communications, +45 2264 0697, tisc@ambu.com

About Ambu A/S

Ever since 1937, Ambu has surpassed expectations with groundbreaking solutions that improve patient care. Millions of patients, clinicians, and health systems worldwide rely on our endoscopy, anesthesia, and patient monitoring solutions for efficiency, safety, and performance. Our ownership of every stage of the product life cycle enables us to work closely with healthcare professionals, maintain a reliable product supply, and uphold full transparency. At our headquarters in Copenhagen, Denmark, and around the world in Europe, North America, and the Asia Pacific, 5,200+ Ambu team members are committed to delivering above and beyond.

Attachments

  • Download announcement as PDF.pdf
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.